Find a cost-saving or cost-effective
drug price in minutes
Using peer-reviewed model replicas, localized to your country and customizable with your data.
What you get
Every analysis produces intuitive visualizations, a one-page brief, and a publication-grade technical report. Click thumbnails to see examples
GENESIS doesn't replace the priority-setting institution. It replaces the spreadsheet inside it.
From question to insight in minutes.
In as little as 4 steps
Choose your model
Pick a faithful replication of a peer-reviewed disease model.
Select your country
One click loads demographics, life tables, costs, and willingness-to-pay thresholds for your country.
Customize with your data
Optionally inject local cost, morbidity or survey data.
Run the analyses
Get rapid insights through intuitive visualizations and tables, a one pager or a detailed technical report.
Glass-box rigor. GENESIS doesn't guess. It replicates.
Everything behind the results is open to inspection.
Peer-reviewed pedigree
Every model is a faithful replication of a landmark published framework (UKPDS, DOC-M, IPECAD, and more).
Full audit trail
Every parameter is sourced, cited, and traceable.
Built-in validation
Each analysis tests model performance against independent epidemiological targets.
Honest by design
Inputs are used as published (never tuned to a target), and every report states its own limits.
Your analysis is yours alone. We don’t sell it or retain it on our servers.
Different methods, the same call.
Every replica reaches the same coverage decision as its published benchmark.
For those who set priorities & the people they serve.
Different questions, the same defensible standard.
Public sector
Cost-effectiveness evidence for ministries, health agencies, and regional bodies, localized to your country.
HTA agencies & payers
Benchmark any submission against an independent, peer-reviewed replica.
Research & advisory
CHEERS-compliant analyses on your own data, ready for journals and grants.
Pharma & biotech teams
Forecast value with your own efficacy data for go/no-go calls and pricing. Your data stays private.
From priority decisions made on faith, to priority decisions made on evidence.
A library that grows with your priorities.
Each model is a faithful replication of a peer-reviewed framework. Don't see your disease area? Sponsor or request a model
Open access for those who need it most.
Commercial subscribers and donors fund sponsored Mission access.
- 10K simulated patients
- 1K PSA iterations
- All models in 194 countries
- Custom treatments
- PDF reports only
- 3 lifetime analyses
- Up to 100K simulated patients
- 1K PSA iterations
- All models in 194 countries
- Custom treatments
- PDF & white-label reports
- Unlimited analyses
- Up to 100K simulated patients
- 1K PSA iterations
- All models in 194 countries
- Custom treatments
- PDF & white-label reports
- Unlimited analyses